Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion type Assertion NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_head.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion description "[The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complete response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_provenance.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion evidence source_evidence_literature NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_provenance.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion SIO_000772 7927216 NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_provenance.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion wasDerivedFrom befree-2016 NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_provenance.
- NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_assertion wasGeneratedBy ECO_0000203 NP1327230.RARx7UwEIBTCX6PVhx-WW9YeHH4J_FwwbXTn_zbLDJhJc130_provenance.